The brains of people with type 1 diabetes react differently to low blood sugar compared with healthy adults, say Yale researchers.
The findings of their new study, published in the Journal of Clinical Investigation, shed light on why many type 1 diabetics...
Building on prior research that examined the use of an arthritis medication to treat vitiligo, a team of Yale dermatologists has successfully applied a novel combination therapy — the medication and light — to restore skin color in patients.
The study,...
Taking five or more prescription medications increases the risk of hospitalization and death in older adults infected with HIV and comparable adults without HIV. The findings of this Yale-led study highlight the potential risks of prescribing additional...
Each year 1 million Americans are diagnosed with heart failure, a serious condition that causes shortness of breath, weakness, and excess fluid. Diuretics are the main therapy for fluid removal but there has long been concern about potential damage to...
A team of Yale researchers developed and tested an automated tool that uses electronic health records to identify patients most at risk of deteriorating while in the hospital.
Led by associate professor of medicine Robert Fogerty, the team used criteria...
For two weeks in December 2017, Yale ophthalmologist Christopher Teng participated in a medical mission to provide free eye care to villagers in Nepal, a country that was devastated by an earthquake just two years prior. The trip was co-sponsored by...
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure of one of these proteins,...
A common vascular disease, deep vein thrombosis (DVT), can cause dangerous blood clots to form in the legs. A study led by a Yale investigator suggests that the location of the clot can make a difference in patient outcomes.
Using data from a large...
